REFERENCES
- Castillo-Mancilla, J. R., S. E. Cohn, S. Krishnan, et al. 2014. Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials. HIV Clinical Trials 15(1): 14–26. doi: 10.1310/hct1501-14.
- Dans, A. L., L. F. Dans, G. H. Guyatt, and S. Richardson, and Evidence-Based Medicine Working Group. 1998. Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Journal of the American Medical Association 279(7): 545–549.
- Emanuel, E. J., D. Wendler, and C. Grady. 2000. What makes clinical research ethical? JAMA 283 (20): 2701–2711. doi: 10.1001/jama.283.20.2701.
- Ford, I., and J. Norrie. 2016. Pragmatic trials. The New England Journal of Medicine 375(5): 454–463. doi: 10.1056/NEJMra1510059.
- Fuller, J. 2013. Rationality and the generalization of randomized controlled trial evidence. Journal of Evaluation in Clinical Practice 19(4): 644–647. doi: 10.1111/jep.12021.
- Hoertel, N., Y. L. Strat, C. Blanco, P. Lavaud, and C. Dubertret. 2012. Generalizability of clinical trial results for generalized anxiety disorder to community samples. Depression and Anxiety 29(7): 614–620. doi: 10.1002/da.21937.
- Humphreys, K., J. C. Blodgett, and L. W. Roberts. 2015. The exclusion of people with psychiatric disorders from medical research. Journal of Psychiatric Research 70: 28–32. doi: 10.1016/j.jpsychires.2015.08.005.
- Liu, K. A., and N. A. Dipietro Mager. 2016. Women’s involvement in clinical trials: Historical perspective and future implications. Pharmacy Practice 14(1): 708–709. doi: 10.18549/PharmPract.2016.01.708.
- London, A. J., and J. Kimmelman. 2019. Clinical trial portfolios: A critical oversight in human research ethics, drug regulation, and policy. Hastings Center Report 49(4): 31–41. doi: 10.1002/hast.1034.
- MacKay, D., and K. Saylor. 2020. Four faces of fair subject selection. The American Journal of Bioethics 20(2): 5–19.
- National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html
- Petticrew, M., P. Tugwell, E. Kristjansson, S. Oliver, E. Ueffing, and V. Welch. 2012. Damned if you do, damned if you don't: Subgroup analysis and equity. Journal of Epidemiology and Community Health 66(1): 95–98. doi: 10.1136/jech.2010.121095.
- Phillips, T. 2011. From the ideal market to the ideal clinic: Constructing a normative standard of fairness for human subjects research. Journal of Medicine and Philosophy 36(1): 79–106. doi: 10.1093/jmp/jhq058.
- Wilson, J. T. 1999. An update on the therapeutic orphan. Pediatrics 104(3 Pt 2): 585–590.
- Wong, J. J., N. Jones, C. Timko, and K. Humphreys. 2018. Exclusion criteria and generalizability in bipolar disorder treatment trials. Contemporary Clinical Trials Communications 9: 130–134. doi: 10.1016/j.conctc.2018.01.009.
- Zhang, T., W. Tsang, H. C. Wijeysundera, and D. T. Ko. 2013. Reporting and representation of ethnic minorities in cardiovascular trials: A systematic review. American Heart Journal 166(1): 52–57. doi: 10.1016/j.ahj.2013.03.022.